• Register
  • Login

European Journal of Molecular & Clinical Medicine

  • Home
  • Browse
    • Current Issue
    • By Issue
    • By Subject
    • Keyword Index
    • Author Index
    • Indexing Databases XML
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Indexing and Abstracting
    • Peer Review Process
    • News
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
Advanced Search

Notice

As part of Open Journals’ initiatives, we create website for scholarly open access journals. If you are responsible for this journal and would like to know more about how to use the editorial system, please visit our website at https://ejournalplus.com or
send us an email to info@ejournalplus.com

We will contact you soon

  1. Home
  2. Volume 10, Issue 1
  3. Author

Online ISSN: 2515-8260

Volume10, Issue1

THE ROLE OF ALDOSTERONE AND GALECTIN-3 INDICATORS IN THE DEVELOPMENT OF FIBROSIS PROCESSES IN CARDIORENAL SYNDROME

    Sayfullaev Mirfuzail Bakhtiyorovich, Gadaev Abdigaffar Gadaevich, Turakulov Rustam Ismatullaevich

European Journal of Molecular & Clinical Medicine, 2023, Volume 10, Issue 1, Pages 3422-3426

  • Show Article
  • Download
  • Cite
  • Statistics
  • Share

Abstract

The role of aldosterone and galectin-3 in the development of fibrotic processes in the heart and kidneys in cardiorenal syndrome that developed against the background of chronic heart failure (CHF). In all three groups of patients under observation, a statistically significant increase (r˂0.05) was found, compared with the reference values of the concentration of galectin -3. Along with this, a statistically significant increase in aldosterone concentration was found in patients of the main group compared to the control group (r<0.001). Also, there was a significant increase in its concentration in patients with low and intermediate ejection fraction of CHF. Thus, in patients with CHF with intermediate and low ejection fraction of the left ventricle, significantly increased concentrations of galecten-3 and aldosterone, indicating the processes of myocardial fibrosis, and their correlation with the severity of the disease, were established.
chronic heart failure, cardiorenal syndrome, galectin-3, aldosterone
Keywords:
    chronic heart failure cardiorenal syndrome galectin-3 aldosterone
  • PDF (204 K)
  • XML
(2023). THE ROLE OF ALDOSTERONE AND GALECTIN-3 INDICATORS IN THE DEVELOPMENT OF FIBROSIS PROCESSES IN CARDIORENAL SYNDROME. European Journal of Molecular & Clinical Medicine, 10(1), 3422-3426.
Sayfullaev Mirfuzail Bakhtiyorovich, Gadaev Abdigaffar Gadaevich, Turakulov Rustam Ismatullaevich. "THE ROLE OF ALDOSTERONE AND GALECTIN-3 INDICATORS IN THE DEVELOPMENT OF FIBROSIS PROCESSES IN CARDIORENAL SYNDROME". European Journal of Molecular & Clinical Medicine, 10, 1, 2023, 3422-3426.
(2023). 'THE ROLE OF ALDOSTERONE AND GALECTIN-3 INDICATORS IN THE DEVELOPMENT OF FIBROSIS PROCESSES IN CARDIORENAL SYNDROME', European Journal of Molecular & Clinical Medicine, 10(1), pp. 3422-3426.
THE ROLE OF ALDOSTERONE AND GALECTIN-3 INDICATORS IN THE DEVELOPMENT OF FIBROSIS PROCESSES IN CARDIORENAL SYNDROME. European Journal of Molecular & Clinical Medicine, 2023; 10(1): 3422-3426.
  • RIS
  • EndNote
  • BibTeX
  • APA
  • MLA
  • Harvard
  • Vancouver
  • Article View: 10
  • PDF Download: 17
  • LinkedIn
  • Twitter
  • Facebook
  • Google
  • Telegram
Journal Information

Publisher:

Email:  editor.ejmcm21@gmail.com

  • Home
  • Glossary
  • News
  • Aims and Scope
  • Privacy Policy
  • Sitemap

 

For Special Issue Proposal : editor.ejmcm21@gmail.com

This journal is licensed under a Creative Commons Attribution 4.0 International (CC-BY 4.0)

Powered by eJournalPlus